375 related articles for article (PubMed ID: 33462760)
21. Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households.
Brand SP; Munywoki P; Walumbe D; Keeling MJ; Nokes DJ
Elife; 2020 Mar; 9():. PubMed ID: 32216871
[TBL] [Abstract][Full Text] [Related]
22. National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study.
Li Y; Johnson EK; Shi T; Campbell H; Chaves SS; Commaille-Chapus C; Dighero I; James SL; Mahé C; Ooi Y; Paget J; van Pomeren T; Viboud C; Nair H
Lancet Respir Med; 2021 Feb; 9(2):175-185. PubMed ID: 32971018
[TBL] [Abstract][Full Text] [Related]
23. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.
Poletti P; Merler S; Ajelli M; Manfredi P; Munywoki PK; Nokes D; Melegaro A
BMC Med; 2015 Mar; 13():49. PubMed ID: 25857701
[TBL] [Abstract][Full Text] [Related]
24. Passive and active immunization against respiratory syncytial virus for the young and old.
Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
[TBL] [Abstract][Full Text] [Related]
25. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
Moline HL; Tannis A; Toepfer AP; Williams JV; Boom JA; Englund JA; Halasa NB; Staat MA; Weinberg GA; Selvarangan R; Michaels MG; Sahni LC; Klein EJ; Stewart LS; Schlaudecker EP; Szilagyi PG; Schuster JE; Goldstein L; Musa S; Piedra PA; Zerr DM; Betters KA; Rohlfs C; Albertin C; Banerjee D; McKeever ER; Kalman C; Clopper BR; ; McMorrow ML; Dawood FS
MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(9):209-214. PubMed ID: 38457312
[TBL] [Abstract][Full Text] [Related]
26. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Fleming-Dutra KE; Jones JM; Roper LE; Prill MM; Ortega-Sanchez IR; Moulia DL; Wallace M; Godfrey M; Broder KR; Tepper NK; Brooks O; Sánchez PJ; Kotton CN; Mahon BE; Long SS; McMorrow ML
MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(41):1115-1122. PubMed ID: 37824423
[TBL] [Abstract][Full Text] [Related]
27. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
[TBL] [Abstract][Full Text] [Related]
28. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
29. Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015.
Jepsen MT; Trebbien R; Emborg HD; Krause TG; Schønning K; Voldstedlund M; Nielsen J; Fischer TK
Euro Surveill; 2018 Jan; 23(3):. PubMed ID: 29386093
[TBL] [Abstract][Full Text] [Related]
30. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
Nokes DJ; Okiro EA; Ngama M; Ochola R; White LJ; Scott PD; English M; Cane PA; Medley GF
Clin Infect Dis; 2008 Jan; 46(1):50-7. PubMed ID: 18171213
[TBL] [Abstract][Full Text] [Related]
31. Respiratory syncytial virus disease morbidity in Australian infants aged 0 to 6 months: a systematic review with narrative synthesis.
Self A; Van Buskirk J; Clark J; Cochrane JE; Knibbs L; Cass-Verco J; Gupta L
BMC Public Health; 2023 Dec; 23(1):2560. PubMed ID: 38129854
[TBL] [Abstract][Full Text] [Related]
32. Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants.
Giannini F; Hogan AB; Sarna M; Glass K; Moore HC
BMC Infect Dis; 2024 May; 24(1):510. PubMed ID: 38773455
[TBL] [Abstract][Full Text] [Related]
33. Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?
Saso A; Kampmann B
Lancet Infect Dis; 2016 Aug; 16(8):e153-63. PubMed ID: 27317449
[TBL] [Abstract][Full Text] [Related]
34. What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus.
Debessai H; Jones JM; Meaney-Delman D; Rasmussen SA
Obstet Gynecol; 2024 Mar; 143(3):e54-e62. PubMed ID: 38061043
[TBL] [Abstract][Full Text] [Related]
35. The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: A meta-analysis.
Zhu T; Zhang C; Yu L; Chen J; Qiu H; Lyu W; Huang S
Virol Sin; 2015 Oct; 30(5):371-8. PubMed ID: 26511990
[TBL] [Abstract][Full Text] [Related]
36. Modeling Respiratory Syncytial Virus Adult Vaccination in the United States With a Dynamic Transmission Model.
Van Effelterre T; Hens N; White LJ; Gravenstein S; Bastian AR; Buyukkaramikli N; Cheng CY; Hartnett J; Krishnarajah G; Weber K; Pastor LH
Clin Infect Dis; 2023 Aug; 77(3):480-489. PubMed ID: 36949605
[TBL] [Abstract][Full Text] [Related]
37. Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.
Cromer D; van Hoek AJ; Newall AT; Pollard AJ; Jit M
Lancet Public Health; 2017 Aug; 2(8):e367-e374. PubMed ID: 28804787
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus vaccine: where are we now and what comes next?
Noor A; Krilov LR
Expert Opin Biol Ther; 2018 Dec; 18(12):1247-1256. PubMed ID: 30426788
[TBL] [Abstract][Full Text] [Related]
39. Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
Riddell CA; Bhat N; Bont LJ; Dupont WD; Feikin DR; Fell DB; Gebretsadik T; Hartert TV; Hutcheon JA; Karron RA; Nair H; Reiner RC; Shi T; Sly PD; Stein RT; Wu P; Zar HJ; Ortiz JR;
Vaccine; 2018 Dec; 36(52):8100-8109. PubMed ID: 30473186
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
Moghadas SM; Shoukat A; Bawden CE; Langley JM; Singer BH; Fitzpatrick MC; Galvani AP
Clin Infect Dis; 2024 May; 78(5):1328-1335. PubMed ID: 38035791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
